Antimicrobial agent-54
Antimicrobial agent-54 is a ciprofloxacin-derived multi-target antimicrobial agent that inhibits E. coli DNA gyrase, S. aureus topoisomerase IV, LpxC and urease with IC50 values of 0.182, 3.501, 0.052 and 6.254 μM, respectively. The MIC of Antimicrobial agent-54 against E. coli ATCC 8739 is 0.20 μM. Antimicrobial agent-54 interferes with bacterial cell division, causes transient membrane disruption in Gram-positive bacteria, and induces aberrant penicillin-binding protein activity in Gram-negative bacteria. Antimicrobial agent-54 can be used in the research of bacterial infections, including multidrug-resistant bacterial infections and mycobacterial infections.
For research use only. We do not sell to patients.
- Formula: C26H26FN5O5
- Molecular Weight:507.51
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
DNA gyrase 0.182 μM (IC50, E. coli) |
topoisomerase IV 3.501 μM (IC50, S. aureus) |
LpxC 0.052 μM (IC50) |
urease 6.254 μM (IC50) |
In Vitro
Antimicrobial agent-54 (compound 10b) inhibits the growth of E. coli ATCC 8739 (MIC = 0.20 μM) in vitro[1].
Antimicrobial agent-54 activates the SOS DNA damage response in Bacillus subtilis UG10, which is evidenced by the formation of RecA aggregates[1].
Antimicrobial agent-54 induces cell elongation, nucleoid condensation, nucleoid-free regions and abnormal cell branching in E. coli W3110, a phenotype consistent with topoisomerase inhibition and potential impairment of penicillin-binding protein function[1].
Antimicrobial agent-54 potently inhibits E. coli DNA gyrase (IC50 = 0.18 μM) and S. aureus topoisomerase IV (IC50 = 3.501 μM), while exhibits low activity against human topoisomerase II (IC50 = 48.05 μM), showing excellent selectivity[1].
Antimicrobial agent-54 potently inhibits nickel-dependent urease with an IC50 value of 6.254 μM[1].
Antimicrobial agent-54 potently inhibits E. coli LpxC with an IC50 value of 0.052 μM[1].
Antimicrobial agent-54 (20 days) exhibits extremely low potential for resistance development against E. coli NCTC 13476 over 20 days, with only a slight increase in its MIC[1].
Antimicrobial agent-54 exhibits low cytotoxicity against human SH-SY5Y (IC50 = 49.62 μM) and WI-38 (IC50 = 59.35 μM) cells, with a favorable selectivity index of 17[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Molecular Weight 507.51
-
Formula C26H26FN5O5
-
SMILES
O=C1C(C(NCC(NO)=O)=O)=CN(C2CC2)C3=C1C=C(F)C(N4CCN(C(C5=CC=CC=C5)=O)CC4)=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
CFSE Dye Dilution Proliferation Assay
The CFSE (carboxyfluorescein diacetate succinimidyl ester) dye dilution proliferation assay is based on the covalent labeling of intracellular proteins by a cell-permeant fluorescent dye that becomes fluorescent upon intracellular ester cleavage and then is stably retained within cells. As labeled cells divide, the dye is partitioned equally between daughter cells, resulting in a stepwise halving of fluorescence intensity that can be quantified by flow cytometry to determine the number of cell divisions undergone by each cell population. This fluorescence dilution approach enables quantitative tracking of lymphocyte proliferation at the single-cell level over multiple rounds of division. CFSE-based proliferation analysis has been widely applied to measure antigen-driven lymphocyte expansion in vitro, where discrete fluorescence peaks correspond to successive cell divisions and allow reconstruction of proliferative history within heterogeneous populations.
-
Dye-dilution cell tracking and proliferation staining
Dye-dilution cell tracking assays quantify cell proliferation by covalently labeling intracellular proteins with a stable fluorescent dye that is equally partitioned between daughter cells during mitosis, resulting in stepwise halving of fluorescence intensity with each cell division as measured by flow cytometry histograms. Carboxyfluorescein diacetate succinimidyl ester (CFSE) is a prototypical dye that diffuses into cells, is enzymatically converted into a fluorescent compound, and then covalently binds intracellular amine groups, producing long-lived fluorescence suitable for tracking multiple rounds of division in vitro and in vivo. Successive generations of dividing cells form discrete peaks of decreasing fluorescence intensity, enabling estimation of proliferation history, precursor frequency, and division index within heterogeneous populations. Alternative dyes such as CellTrace Violet (CTV) and far-red membrane dyes (e. g. , PKH26) follow the same dilution principle but differ
-
Gram Staining of Tissue Sections
Gram staining of tissue sections is a histochemical technique used to differentiate Gram-positive and Gram-negative bacteria within histological specimens based on differences in bacterial cell wall structure and dye retention, adapted from classical bacteriological Gram staining into tissue-compatible “histological Gram stain” variants. In tissue applications, modifications of the Brown-Hopps and Brown-Brenn methods are commonly used to improve differentiation of microorganisms embedded within host connective tissue and to reduce overstaining or loss of Gram-negative signal, which are known limitations of earlier approaches. The principle relies on crystal violet-iodine complex retention in Gram-positive organisms and subsequent decolorization and counterstaining steps that allow contrast visualization of Gram-negative organisms against tissue background.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Antimicrobial agent-54
- Antimicrobial agent54
- Antimicrobial agent 54
- Antibiotic
- Bacterial
- Topoisomerase
- Urease
- H. pylori ATCC 700392
- Gram-negative bacteria
- urease
- mycobacterial species
- E. coli DNA gyrase
- Gram-positive bacteria
- human topoisomerase II
- Bacillus subtilis 2020
- LpxC
- S. aureus topoisomerase IV
- Inhibitor
- inhibitor
- inhibit